secwatch.observer — SEC 8-K summary
======================================

Issuer:     CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
CIK:        0001801170
Form:       8-K
Filed at:   2023-01-10T23:59:59+00:00
Accession:  0001801170-23-000004
Event type: leadership
Sentiment:  positive
Materiality: 0.80
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Clover Health appoints Jamie Reynoso as CEO of Medicare Advantage and issues FY2023 partial guidance
--------------------------------------------------------------------------------

- Appointed Jamie L. Reynoso as Chief Executive Officer of Medicare Advantage, effective January 6, 2023.
- Issued partial FY2023 guidance: Insurance revenue $1.15B-$1.20B, Insurance MCR 89%-91%.
- Andrew Toy to present at 41st Annual J.P. Morgan Healthcare Conference on January 11, 2023.
- Non-Insurance revenue guidance $0.75B-$0.80B, Non-Insurance MCR 98%-100%.
- Strategic shift to prioritize profitability, expecting favorability in 2023 MCR and growth in Insurance top-line revenue.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1801170/000180117023000004/0001801170-23-000004-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1801170/000180117023000004/clov-20230106.htm
  HTML page:      https://secwatch.observer/filing/0001801170-23-000004

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer